These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
525 related items for PubMed ID: 15724243
1. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects. Piriou ER, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D. Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243 [Abstract] [Full Text] [Related]
2. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy. Piriou E, Jansen CA, van Dort K, De Cuyper I, Nanlohy NM, Lange JM, van Oers MH, Miedema F, van Baarle D. J Immunol; 2005 Aug 01; 175(3):2010-7. PubMed ID: 16034146 [Abstract] [Full Text] [Related]
3. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity. Jansen CA, Piriou E, De Cuyper IM, van Dort K, Lange JM, Miedema F, van Baarle D. Antivir Ther; 2006 Aug 01; 11(1):105-16. PubMed ID: 16518966 [Abstract] [Full Text] [Related]
4. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis. Klatt T, Ouyang Q, Flad T, Koetter I, Bühring HJ, Kalbacher H, Pawelec G, Müller CA. J Rheumatol; 2005 Feb 01; 32(2):239-51. PubMed ID: 15693083 [Abstract] [Full Text] [Related]
5. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen. Mo WN, Tang AZ, Zhou L, Huang GW, Wang Z, Zeng Y. Chin Med J (Engl); 2009 May 20; 122(10):1173-8. PubMed ID: 19493466 [Abstract] [Full Text] [Related]
6. Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers. Benninger-Döring G, Pepperl S, Deml L, Modrow S, Wolf H, Jilg W. Virology; 1999 Nov 25; 264(2):289-97. PubMed ID: 10562493 [Abstract] [Full Text] [Related]
7. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus. Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ. J Infect Dis; 2001 Aug 01; 184(3):256-67. PubMed ID: 11443550 [Abstract] [Full Text] [Related]
8. In situ RT-PCR detection of Epstein-Barr virus immediate-early transcripts in CD4+ and CD8+ T lymphocytes. Guan M, Romano G, Henderson EE. Anticancer Res; 1998 Aug 01; 18(5A):3171-80. PubMed ID: 9858880 [Abstract] [Full Text] [Related]
9. Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE. Berner BR, Tary-Lehmann M, Yonkers NL, Askari AD, Lehmann PV, Anthony DD. Cell Immunol; 2005 May 01; 235(1):29-38. PubMed ID: 16181618 [Abstract] [Full Text] [Related]
10. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. O'Sullivan CE, Peng R, Cole KS, Montelaro RC, Sturgeon T, Jenson HB, Ling PD. J Med Virol; 2002 Jul 01; 67(3):320-6. PubMed ID: 12116021 [Abstract] [Full Text] [Related]
11. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses. Ostrowski MA, Gu JX, Kovacs C, Freedman J, Luscher MA, MacDonald KS. J Infect Dis; 2001 Nov 15; 184(10):1268-78. PubMed ID: 11679915 [Abstract] [Full Text] [Related]
12. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI. Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945 [Abstract] [Full Text] [Related]
13. Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient. Piriou ER, van Dort K, Weel JF, Bemelman FJ, Gamadia LE, van Oers MH, van Baarle D. Clin Immunol; 2006 Apr 15; 119(1):16-20. PubMed ID: 16386961 [Abstract] [Full Text] [Related]
14. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes. Kaiser P, Joos B, Niederöst B, Weber R, Günthard HF, Fischer M. J Virol; 2007 Sep 15; 81(18):9693-706. PubMed ID: 17609262 [Abstract] [Full Text] [Related]
15. A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers. Yu HX, Srinivasan N, Ren EE, Chan SH. Tissue Antigens; 2005 Jun 15; 65(6):539-43. PubMed ID: 15896201 [Abstract] [Full Text] [Related]
16. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. Tan LC, Gudgeon N, Annels NE, Hansasuta P, O'Callaghan CA, Rowland-Jones S, McMichael AJ, Rickinson AB, Callan MF. J Immunol; 1999 Feb 01; 162(3):1827-35. PubMed ID: 9973448 [Abstract] [Full Text] [Related]
17. Epstein-Barr virus infects B and non-B lymphocytes in HIV-1-infected children and adolescents. Bekker V, Scherpbier H, Beld M, Piriou E, van Breda A, Lange J, van Leth F, Jurriaans S, Alders S, Wertheim-van Dillen P, van Baarle D, Kuijpers T. J Infect Dis; 2006 Nov 01; 194(9):1323-30. PubMed ID: 17041860 [Abstract] [Full Text] [Related]
18. The human T cell immune response to Epstein-Barr virus. Landais E, Saulquin X, Houssaint E. Int J Dev Biol; 2005 Nov 01; 49(2-3):285-92. PubMed ID: 15906243 [Abstract] [Full Text] [Related]
19. EBV-specific memory CD8+ T cell phenotype and function in stable solid organ transplant patients. Macedo C, Donnenberg A, Popescu I, Reyes J, Abu-Elmagd K, Shapiro R, Zeevi A, Fung JJ, Storkus WJ, Metes D. Transpl Immunol; 2005 Jun 01; 14(2):109-16. PubMed ID: 15935301 [Abstract] [Full Text] [Related]